These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1721676

  • 21. Cloning and expression of the cathepsin F-like cysteine protease gene in Escherichia coli and its characterization.
    Joo HS, Koo KB, Park KI, Bae SH, Yun JW, Chang CS, Choi JW.
    J Microbiol; 2007 Apr; 45(2):158-67. PubMed ID: 17483802
    [Abstract] [Full Text] [Related]

  • 22. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
    Chavan SJ, Bornmann WG, Flexner C, Prochaska HJ.
    Arch Biochem Biophys; 1995 Dec 01; 324(1):143-52. PubMed ID: 7503549
    [Abstract] [Full Text] [Related]

  • 23. Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors.
    Debyser Z, De Vreese K, Knops-Gerrits PP, Baekelandt V, Bhikhabhai R, Strandberg B, Pauwels R, Anné J, Desmyter J, De Clercq E.
    Mol Pharmacol; 1993 Apr 01; 43(4):521-6. PubMed ID: 7682649
    [Abstract] [Full Text] [Related]

  • 24. HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase.
    Balzarini J, Karlsson A, Pérez-Pérez MJ, Vrang L, Walbers J, Zhang H, Oberg B, Vandamme AM, Camarasa MJ, De Clercq E.
    Virology; 1993 Jan 01; 192(1):246-53. PubMed ID: 7685964
    [Abstract] [Full Text] [Related]

  • 25. Molecular approaches to AIDS vaccine development using baculovirus expression vectors.
    Kang CY.
    Methods Mol Biol; 1995 Jan 01; 39():295-315. PubMed ID: 7542523
    [No Abstract] [Full Text] [Related]

  • 26. [Cloning and expression, in Escherichia coli, of reverse transcriptase from Rous sarcoma virus].
    Mel'nikov AA, Molnar J, Horvath P, Fodor I.
    Dokl Akad Nauk SSSR; 1988 Jan 01; 299(2):486-9. PubMed ID: 2455622
    [No Abstract] [Full Text] [Related]

  • 27. Overproduction of human immunodeficiency virus type I reverse transcriptase in Escherichia coli and purification of the enzyme.
    Saitoh A, Iwasaki H, Nakata A, Adachi A, Shinagawa H.
    Microbiol Immunol; 1990 Jan 01; 34(6):509-21. PubMed ID: 1699113
    [Abstract] [Full Text] [Related]

  • 28. Comparative purification of recombinant HIV-1 and HIV-2 reverse transcriptase: preparation of heterodimeric enzyme devoid of unprocessed gene product.
    Warren TC, Miglietta JJ, Shrutkowski A, Rose JM, Rogers SL, Lubbe K, Shih CK, Caviness GO, Ingraham R, Palladino DE.
    Protein Expr Purif; 1992 Dec 01; 3(6):479-87. PubMed ID: 1283095
    [Abstract] [Full Text] [Related]

  • 29. Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli.
    Müller B, Restle T, Weiss S, Gautel M, Sczakiel G, Goody RS.
    J Biol Chem; 1989 Aug 25; 264(24):13975-8. PubMed ID: 2474539
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
    Wakefield JK, Jablonski SA, Morrow CD.
    J Virol; 1992 Nov 25; 66(11):6806-12. PubMed ID: 1383571
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reconstitution in vitro of RNase H activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase.
    Hostomsky Z, Hostomska Z, Hudson GO, Moomaw EW, Nodes BR.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1148-52. PubMed ID: 1705027
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. HIV-1 reverse transcriptase purified from a recombinant strain of Escherichia coli.
    Clark PK, Ferris AL, Miller DA, Hizi A, Kim KW, Deringer-Boyer SM, Mellini ML, Clark AD, Arnold GF, Lebherz WB.
    AIDS Res Hum Retroviruses; 1990 Jun 15; 6(6):753-64. PubMed ID: 1694680
    [Abstract] [Full Text] [Related]

  • 37. Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure.
    Ferris AL, Hizi A, Showalter SD, Pichuantes S, Babe L, Craik CS, Hughes SH.
    Virology; 1990 Apr 15; 175(2):456-64. PubMed ID: 1691562
    [Abstract] [Full Text] [Related]

  • 38. Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment.
    Clark AD, Jacobo-Molina A, Clark P, Hughes SH, Arnold E.
    Methods Enzymol; 1995 Apr 15; 262():171-85. PubMed ID: 8594346
    [No Abstract] [Full Text] [Related]

  • 39. Purification, characterization and crystallization of recombinant HIV-1 reverse transcriptase.
    Bhikhabhai R, Joelson T, Unge T, Strandberg B, Carlsson T, Lövgren S.
    J Chromatogr; 1992 Jun 26; 604(1):157-70. PubMed ID: 1379251
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.